Matt has a 1st class honours degree in Industrial Design. He founded Aircraft Medical in June 2001 with the vision to build a full infrastructure medical devices company. He twice won the coveted Royal Society of Arts design award, an achievement shared with Jonathon Ive (Head of Design at Apple Inc.). He has lived and worked in New York, Lisbon and London as well as working at the UN Centre for Design Research on medical devices. Matt was awarded the title of 'Emerging Entrepreneur of the Year' by Scotland's Entrepreneurial Exchange and was recently named "Young Scot of the Year". Matt is an advisor to the Royal Society of Arts and sits on The Wellcome Trust's Expert Review Group. Matt is the recent winner of the coveted 2010 Gannochy Trust Innovation Award of the Royal Society of Edinburgh.
Bryan was appointed chairman in March 2009 having been a non-executive director of the Company since early 2006. He has thirty years of commercial, business development and general management experience in the pharmaceutical and medical device industries. Bryan is the founder and CEO of EUSA Pharma Inc, a specialty pharmaceutical company. Founded in 2006, EUSA Pharma has 250 specialist staff and operates in 80 countries. Previously Bryan was CEO of Zeneus Pharma, which he founded following the acquisition of Elan Corp’s European business. Zeneus was subsequently acquired by Cephalon in late 2005 for $360m after two highly successful years of rapid growth and profitable trading. Between 1999 and 2003, Bryan was president of ConvaTec, EMEA, Bristol-Myers Squibb’s medical device and wound care business. Prior to that, Bryan held various senior positions at Merck & Co Inc., most recently as head of the European office. Bryan holds an MBA from the University of Durham and a BSc in Pharmacology from the University of Aberdeen.
Malcolm was until recently a senior corporate finance partner, and is now a consultant to Shepherd & Wedderburn, the UK commercial solicitors. He has over thirty years experience as a commercial lawyer with particular emphasis on funds, together with international and Stock Exchange related transactions. Malcolm is a director of AIM-quoted Trading Emissions and is the company secretary of Axis-Shield plc (listed in London and Oslo). In addition, he is a director of several private companies and a member of the Strategic Advisory Board for the Business School at Glasgow University.
Finance Director and Company Secretary
Alison is a director and has worked with the Company since 2004 overseeing the company’s accounts, tax planning and investor relations until 2010 when her role became that of full-time finance director and company secretary. She is a chartered accountant, and after fifteen years working with Deloitte & Touche and KPMG, she founded DC Consulting in 2000, a corporate finance house specialising in the smaller company market. She was recently nominated for the Institute of Directors Female Director of the Year Award. Alison has demonstrated a significant track record in the medical technology sector which has led to a number of non-executive appointments and ongoing consultancy roles.
Commercial Director and General Counsel
Philippa was appointed in 2012, and is an experienced commercial IP lawyer with a particular focus on patent litigation and commercial strategy for life sciences companies. Philippa has a degree in Biochemistry and trained at Linklaters LLP in London then most recently was a partner at DLA Piper LLP. She has worked with the Company since 2007 advising on IP matters as well as their commercial agreements. Philippa has advised a broad range of pharmaceutical, biotech, regen med and medical device clients on IP and commercial matters including Pfizer, AstraZeneca, J&J, Takeda, Zimmer and various stem cell companies including Roslin Cells. Philippa speaks and writes regularly on legal issues for life sciences companies, particularly patent litigation and has articles published in several peer reviewed journals.
Patrick has over 25 years of experience in the medical device industry in North America and in Europe. He is a founding board member of Optos Plc, a world leading retinal imaging company listed on the LSE. He is chairman of Vertical Asset Management Limited and was previously chairman of AIM quoted Tissue Science Laboratories plc until its sale to Covidien Inc in 2008. In 1975 he cofounded Support Systems International, and later became the chairman and chief executive officer before its eventual sale to Hillenbrand Industries, Inc. in 1985. Patrick has a degree in Engineering from the University of Southampton and is a fellow of the Institute of Chartered Accountants in England and Wales. Patrick is a shareholder and advisor to Aircraft Medical.
Charles is an experienced healthcare investor and corporate finance adviser with a particular focus on medical technology. He is currently a director of Stanmore Implants Worldwide Limited, the world-renowned custom implant specialist, and chairman of Trust William Limited, a natural consumer health direct retailer. He is also a strategic adviser to other companies in the medical sector including Asterand plc, the LSE-listed tissue-banking specialist. He was previously led investments in a number of medtech companies including Medivance, AOI Medical, Cozart and Stanmore Implants. Prior to that, he was head of healthcare corporate finance at both Numis Securities and Nomura International. He is a member of the techMARK Advisory Group at the London Stock Exchange.
SENIOR MANAGEMENT TEAM
Jeremy joined Aircraft Medical in 2006 having been a consultant to the Company in 2004. He has 18 years experience implementing operational systems and general management in medical device companies. Previously he joined Creos International to set up its worldwide customer support function and following its acquisition by its largest customer to become Medstone International, he then became General Manager of Medstone and Zenith Medical Systems. More recently he was appointed General Manager of Applied Neuro-Diagnostics taking the company from inception to delivering medical equipment from a bespoke manufacturing unit in 18 months. Jeremy has a wealth of experience in managing the development, production and delivery of high-tech medical products to major OEMs such as GE Medical Systems and Philips. He is an expert reviewer to the Wellcome Trust.
VP sales and marketing (Global)
Moh joined Aircraft in July 2012. He has 18 years experience working for global organisations with 12 years in medical devices industry. Previously he worked at Smiths Medical in the UK where he managed the Respiratory Care portfolio. He had global marketing responsibility for managing a team to introduce new products, develop marketing initiatives and driving the product road map. Prior to that he worked for ResMed in Australia as a Senior Global Market Manager where he managed and launched several products globally. Moh began his career in medical devices at Fisher and Paykel Healthcare in New Zealand where he was involved from product inception to commercial launch of internationally successful products to which Moh was a named patentee. Moh has an MBA from the University of Otago and Master in Engineering from the University of Auckland.